nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—Cytochrome P450 3A Inhibitors—Saquinavir—acquired immunodeficiency syndrome	0.202	0.336	CiPCiCtD
Telaprevir—Cytochrome P450 3A Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.153	0.255	CiPCiCtD
Telaprevir—ALB—acquired immunodeficiency syndrome	0.112	1	CbGaD
Telaprevir—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.0958	0.159	CiPCiCtD
Telaprevir—Cytochrome P450 3A Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0929	0.154	CiPCiCtD
Telaprevir—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0581	0.0964	CiPCiCtD
Telaprevir—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0333	0.186	CbGbCtD
Telaprevir—ALB—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0784	CbGbCtD
Telaprevir—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0134	0.0752	CbGbCtD
Telaprevir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0107	0.0598	CbGbCtD
Telaprevir—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00967	0.0541	CbGbCtD
Telaprevir—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00835	0.0467	CbGbCtD
Telaprevir—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0081	0.0454	CbGbCtD
Telaprevir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00733	0.041	CbGbCtD
Telaprevir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00733	0.041	CbGbCtD
Telaprevir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00703	0.0393	CbGbCtD
Telaprevir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00681	0.0381	CbGbCtD
Telaprevir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00641	0.0359	CbGbCtD
Telaprevir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00641	0.0359	CbGbCtD
Telaprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.00613	0.459	CbGpPWpGaD
Telaprevir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00579	0.0324	CbGbCtD
Telaprevir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00579	0.0324	CbGbCtD
Telaprevir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00544	0.0304	CbGbCtD
Telaprevir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.005	0.028	CbGbCtD
Telaprevir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00486	0.0272	CbGbCtD
Telaprevir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00439	0.0246	CbGbCtD
Telaprevir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00439	0.0246	CbGbCtD
Telaprevir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00421	0.0236	CbGbCtD
Telaprevir—CELA1—skin of body—acquired immunodeficiency syndrome	0.00199	0.071	CbGeAlD
Telaprevir—ORM1—saliva—acquired immunodeficiency syndrome	0.00167	0.0596	CbGeAlD
Telaprevir—CMA1—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00161	0.121	CbGpPWpGaD
Telaprevir—CELA1—nervous system—acquired immunodeficiency syndrome	0.00123	0.0439	CbGeAlD
Telaprevir—CELA1—central nervous system—acquired immunodeficiency syndrome	0.00118	0.0423	CbGeAlD
Telaprevir—CTSS—Endosomal/Vacuolar pathway—HLA-B—acquired immunodeficiency syndrome	0.00106	0.0791	CbGpPWpGaD
Telaprevir—CMA1—skin of body—acquired immunodeficiency syndrome	0.00103	0.037	CbGeAlD
Telaprevir—CELA1—brain—acquired immunodeficiency syndrome	0.000939	0.0336	CbGeAlD
Telaprevir—CMA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000837	0.0299	CbGeAlD
Telaprevir—CMA1—digestive system—acquired immunodeficiency syndrome	0.000827	0.0296	CbGeAlD
Telaprevir—CMA1—blood—acquired immunodeficiency syndrome	0.000788	0.0282	CbGeAlD
Telaprevir—CMA1—bone marrow—acquired immunodeficiency syndrome	0.000762	0.0273	CbGeAlD
Telaprevir—CTSK—retina—acquired immunodeficiency syndrome	0.000759	0.0271	CbGeAlD
Telaprevir—CMA1—lung—acquired immunodeficiency syndrome	0.000691	0.0247	CbGeAlD
Telaprevir—CTSK—skin of body—acquired immunodeficiency syndrome	0.000666	0.0238	CbGeAlD
Telaprevir—CTSS—retina—acquired immunodeficiency syndrome	0.000665	0.0238	CbGeAlD
Telaprevir—CTSS—skin of body—acquired immunodeficiency syndrome	0.000584	0.0209	CbGeAlD
Telaprevir—CTSK—lymphoid tissue—acquired immunodeficiency syndrome	0.000539	0.0193	CbGeAlD
Telaprevir—CTSK—digestive system—acquired immunodeficiency syndrome	0.000533	0.0191	CbGeAlD
Telaprevir—CTSK—blood—acquired immunodeficiency syndrome	0.000508	0.0182	CbGeAlD
Telaprevir—CTSK—bone marrow—acquired immunodeficiency syndrome	0.000491	0.0176	CbGeAlD
Telaprevir—CTSK—spinal cord—acquired immunodeficiency syndrome	0.000489	0.0175	CbGeAlD
Telaprevir—CTSS—lymphoid tissue—acquired immunodeficiency syndrome	0.000473	0.0169	CbGeAlD
Telaprevir—CMA1—lymph node—acquired immunodeficiency syndrome	0.000472	0.0169	CbGeAlD
Telaprevir—CTSK—vagina—acquired immunodeficiency syndrome	0.000471	0.0168	CbGeAlD
Telaprevir—CTSS—digestive system—acquired immunodeficiency syndrome	0.000467	0.0167	CbGeAlD
Telaprevir—CTSK—lung—acquired immunodeficiency syndrome	0.000445	0.0159	CbGeAlD
Telaprevir—CTSS—blood—acquired immunodeficiency syndrome	0.000445	0.0159	CbGeAlD
Telaprevir—CTSS—bone marrow—acquired immunodeficiency syndrome	0.00043	0.0154	CbGeAlD
Telaprevir—CTSS—spinal cord—acquired immunodeficiency syndrome	0.000429	0.0153	CbGeAlD
Telaprevir—CTSS—vagina—acquired immunodeficiency syndrome	0.000412	0.0147	CbGeAlD
Telaprevir—CTSK—nervous system—acquired immunodeficiency syndrome	0.000412	0.0147	CbGeAlD
Telaprevir—CTSK—central nervous system—acquired immunodeficiency syndrome	0.000397	0.0142	CbGeAlD
Telaprevir—CTSS—lung—acquired immunodeficiency syndrome	0.00039	0.0139	CbGeAlD
Telaprevir—CTSS—nervous system—acquired immunodeficiency syndrome	0.000361	0.0129	CbGeAlD
Telaprevir—CTSS—central nervous system—acquired immunodeficiency syndrome	0.000348	0.0124	CbGeAlD
Telaprevir—CTSK—brain—acquired immunodeficiency syndrome	0.000315	0.0113	CbGeAlD
Telaprevir—CTSK—lymph node—acquired immunodeficiency syndrome	0.000304	0.0109	CbGeAlD
Telaprevir—CMA1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000304	0.0228	CbGpPWpGaD
Telaprevir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000303	0.0108	CbGeAlD
Telaprevir—CTSS—brain—acquired immunodeficiency syndrome	0.000276	0.00987	CbGeAlD
Telaprevir—CTSS—lymph node—acquired immunodeficiency syndrome	0.000267	0.00954	CbGeAlD
Telaprevir—ORM1—blood—acquired immunodeficiency syndrome	0.000266	0.0095	CbGeAlD
Telaprevir—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000257	0.00919	CbGeAlD
Telaprevir—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000256	0.00915	CbGeAlD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000255	0.0191	CbGpPWpGaD
Telaprevir—ORM1—lung—acquired immunodeficiency syndrome	0.000233	0.00833	CbGeAlD
Telaprevir—CTSS—Antigen processing-Cross presentation—HLA-B—acquired immunodeficiency syndrome	0.000216	0.0162	CbGpPWpGaD
Telaprevir—ORM1—nervous system—acquired immunodeficiency syndrome	0.000216	0.00771	CbGeAlD
Telaprevir—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000214	0.00766	CbGeAlD
Telaprevir—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000208	0.00742	CbGeAlD
Telaprevir—ORM1—lymph node—acquired immunodeficiency syndrome	0.000159	0.0057	CbGeAlD
Telaprevir—ALB—brain—acquired immunodeficiency syndrome	0.000145	0.00517	CbGeAlD
Telaprevir—ALB—lymph node—acquired immunodeficiency syndrome	0.00014	0.00499	CbGeAlD
Telaprevir—Urinary tract disorder—Indinavir—acquired immunodeficiency syndrome	0.000136	0.00207	CcSEcCtD
Telaprevir—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00206	CcSEcCtD
Telaprevir—Urethral disorder—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00206	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000132	0.00201	CcSEcCtD
Telaprevir—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.000132	0.00201	CcSEcCtD
Telaprevir—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00013	0.00199	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00013	0.00198	CcSEcCtD
Telaprevir—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.00197	CcSEcCtD
Telaprevir—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00196	CcSEcCtD
Telaprevir—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00196	CcSEcCtD
Telaprevir—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00195	CcSEcCtD
Telaprevir—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.00193	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.00192	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000126	0.00191	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000124	0.00188	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000124	0.00925	CbGpPWpGaD
Telaprevir—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00188	CcSEcCtD
Telaprevir—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00188	CcSEcCtD
Telaprevir—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.00188	CcSEcCtD
Telaprevir—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.00188	CcSEcCtD
Telaprevir—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.00187	CcSEcCtD
Telaprevir—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.00187	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.00187	CcSEcCtD
Telaprevir—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.00186	CcSEcCtD
Telaprevir—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.00185	CcSEcCtD
Telaprevir—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00185	CcSEcCtD
Telaprevir—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00012	0.00183	CcSEcCtD
Telaprevir—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.00182	CcSEcCtD
Telaprevir—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.00181	CcSEcCtD
Telaprevir—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000119	0.00181	CcSEcCtD
Telaprevir—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000119	0.00181	CcSEcCtD
Telaprevir—Infection—Abacavir—acquired immunodeficiency syndrome	0.000119	0.00181	CcSEcCtD
Telaprevir—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.0018	CcSEcCtD
Telaprevir—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.0018	CcSEcCtD
Telaprevir—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000118	0.00179	CcSEcCtD
Telaprevir—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00179	CcSEcCtD
Telaprevir—ABCB1—retina—acquired immunodeficiency syndrome	0.000117	0.0042	CbGeAlD
Telaprevir—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000117	0.00178	CcSEcCtD
Telaprevir—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000117	0.00178	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.00178	CcSEcCtD
Telaprevir—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00178	CcSEcCtD
Telaprevir—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000116	0.00416	CbGeAlD
Telaprevir—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000116	0.00177	CcSEcCtD
Telaprevir—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00176	CcSEcCtD
Telaprevir—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00173	CcSEcCtD
Telaprevir—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00173	CcSEcCtD
Telaprevir—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.00173	CcSEcCtD
Telaprevir—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.00173	CcSEcCtD
Telaprevir—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.00172	CcSEcCtD
Telaprevir—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.0017	CcSEcCtD
Telaprevir—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.00169	CcSEcCtD
Telaprevir—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00169	CcSEcCtD
Telaprevir—CYP3A4—blood—acquired immunodeficiency syndrome	0.000111	0.00397	CbGeAlD
Telaprevir—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00011	0.00167	CcSEcCtD
Telaprevir—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00167	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.00166	CcSEcCtD
Telaprevir—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00166	CcSEcCtD
Telaprevir—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00166	CcSEcCtD
Telaprevir—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.00165	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.00165	CcSEcCtD
Telaprevir—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000108	0.00165	CcSEcCtD
Telaprevir—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.00165	CcSEcCtD
Telaprevir—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00164	CcSEcCtD
Telaprevir—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000108	0.00164	CcSEcCtD
Telaprevir—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00162	CcSEcCtD
Telaprevir—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000105	0.00161	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.0016	CcSEcCtD
Telaprevir—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.0016	CcSEcCtD
Telaprevir—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.0016	CcSEcCtD
Telaprevir—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000105	0.0016	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000105	0.00159	CcSEcCtD
Telaprevir—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000104	0.00159	CcSEcCtD
Telaprevir—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00158	CcSEcCtD
Telaprevir—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00158	CcSEcCtD
Telaprevir—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.00157	CcSEcCtD
Telaprevir—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.00157	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000103	0.00157	CcSEcCtD
Telaprevir—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000103	0.00157	CcSEcCtD
Telaprevir—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.00156	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000102	0.00762	CbGpPWpGaD
Telaprevir—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00155	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000102	0.0076	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000101	0.00155	CcSEcCtD
Telaprevir—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00153	CcSEcCtD
Telaprevir—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00153	CcSEcCtD
Telaprevir—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.0001	0.00153	CcSEcCtD
Telaprevir—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00152	CcSEcCtD
Telaprevir—Urticaria—Nevirapine—acquired immunodeficiency syndrome	9.97e-05	0.00152	CcSEcCtD
Telaprevir—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	9.96e-05	0.00152	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	9.94e-05	0.00744	CbGpPWpGaD
Telaprevir—Pruritus—Didanosine—acquired immunodeficiency syndrome	9.87e-05	0.0015	CcSEcCtD
Telaprevir—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.0015	CcSEcCtD
Telaprevir—Vomiting—Amprenavir—acquired immunodeficiency syndrome	9.73e-05	0.00148	CcSEcCtD
Telaprevir—Syncope—Delavirdine—acquired immunodeficiency syndrome	9.73e-05	0.00148	CcSEcCtD
Telaprevir—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	9.65e-05	0.00147	CcSEcCtD
Telaprevir—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	9.65e-05	0.00147	CcSEcCtD
Telaprevir—Rash—Amprenavir—acquired immunodeficiency syndrome	9.65e-05	0.00147	CcSEcCtD
Telaprevir—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	9.64e-05	0.00147	CcSEcCtD
Telaprevir—Shock—Indinavir—acquired immunodeficiency syndrome	9.63e-05	0.00147	CcSEcCtD
Telaprevir—Urticaria—Stavudine—acquired immunodeficiency syndrome	9.62e-05	0.00147	CcSEcCtD
Telaprevir—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	9.6e-05	0.00146	CcSEcCtD
Telaprevir—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	9.59e-05	0.00146	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	9.59e-05	0.00146	CcSEcCtD
Telaprevir—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	9.55e-05	0.00146	CcSEcCtD
Telaprevir—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	9.53e-05	0.00145	CcSEcCtD
Telaprevir—Skin disorder—Indinavir—acquired immunodeficiency syndrome	9.51e-05	0.00145	CcSEcCtD
Telaprevir—Urticaria—Abacavir—acquired immunodeficiency syndrome	9.48e-05	0.00145	CcSEcCtD
Telaprevir—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	9.45e-05	0.00144	CcSEcCtD
Telaprevir—Anaemia—Ritonavir—acquired immunodeficiency syndrome	9.27e-05	0.00141	CcSEcCtD
Telaprevir—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	9.21e-05	0.0014	CcSEcCtD
Telaprevir—Shock—Efavirenz—acquired immunodeficiency syndrome	9.1e-05	0.00139	CcSEcCtD
Telaprevir—Nausea—Amprenavir—acquired immunodeficiency syndrome	9.09e-05	0.00139	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	9.09e-05	0.00139	CcSEcCtD
Telaprevir—Fatigue—Zidovudine—acquired immunodeficiency syndrome	9.08e-05	0.00138	CcSEcCtD
Telaprevir—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	9.07e-05	0.00138	CcSEcCtD
Telaprevir—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	9.06e-05	0.00138	CcSEcCtD
Telaprevir—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.00137	CcSEcCtD
Telaprevir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	9e-05	0.00137	CcSEcCtD
Telaprevir—CYP3A4—nervous system—acquired immunodeficiency syndrome	9e-05	0.00322	CbGeAlD
Telaprevir—Syncope—Ritonavir—acquired immunodeficiency syndrome	9e-05	0.00137	CcSEcCtD
Telaprevir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	8.99e-05	0.00137	CcSEcCtD
Telaprevir—Anaemia—Saquinavir—acquired immunodeficiency syndrome	8.92e-05	0.00136	CcSEcCtD
Telaprevir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	8.88e-05	0.00135	CcSEcCtD
Telaprevir—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.87e-05	0.00135	CcSEcCtD
Telaprevir—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	8.82e-05	0.00134	CcSEcCtD
Telaprevir—Rash—Didanosine—acquired immunodeficiency syndrome	8.8e-05	0.00134	CcSEcCtD
Telaprevir—Infection—Delavirdine—acquired immunodeficiency syndrome	8.79e-05	0.00134	CcSEcCtD
Telaprevir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.79e-05	0.00134	CcSEcCtD
Telaprevir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	8.72e-05	0.00133	CcSEcCtD
Telaprevir—Shock—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.00133	CcSEcCtD
Telaprevir—Asthenia—Stavudine—acquired immunodeficiency syndrome	8.69e-05	0.00132	CcSEcCtD
Telaprevir—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	8.67e-05	0.00132	CcSEcCtD
Telaprevir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	8.67e-05	0.0031	CbGeAlD
Telaprevir—Syncope—Saquinavir—acquired immunodeficiency syndrome	8.66e-05	0.00132	CcSEcCtD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—acquired immunodeficiency syndrome	8.62e-05	0.00646	CbGpPWpGaD
Telaprevir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	8.6e-05	0.00131	CcSEcCtD
Telaprevir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	8.6e-05	0.00131	CcSEcCtD
Telaprevir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	8.59e-05	0.00131	CcSEcCtD
Telaprevir—Pruritus—Stavudine—acquired immunodeficiency syndrome	8.57e-05	0.00131	CcSEcCtD
Telaprevir—Asthenia—Abacavir—acquired immunodeficiency syndrome	8.56e-05	0.00131	CcSEcCtD
Telaprevir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	8.51e-05	0.0013	CcSEcCtD
Telaprevir—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	8.49e-05	0.00129	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	8.48e-05	0.00129	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	8.45e-05	0.00129	CcSEcCtD
Telaprevir—Pruritus—Abacavir—acquired immunodeficiency syndrome	8.44e-05	0.00129	CcSEcCtD
Telaprevir—Fatigue—Indinavir—acquired immunodeficiency syndrome	8.44e-05	0.00129	CcSEcCtD
Telaprevir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	8.37e-05	0.00127	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—MBL2—acquired immunodeficiency syndrome	8.36e-05	0.00626	CbGpPWpGaD
Telaprevir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.34e-05	0.00298	CbGeAlD
Telaprevir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	8.31e-05	0.00127	CcSEcCtD
Telaprevir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	8.29e-05	0.00126	CcSEcCtD
Telaprevir—Nausea—Didanosine—acquired immunodeficiency syndrome	8.29e-05	0.00126	CcSEcCtD
Telaprevir—Syncope—Lamivudine—acquired immunodeficiency syndrome	8.26e-05	0.00126	CcSEcCtD
Telaprevir—ABCB1—digestive system—acquired immunodeficiency syndrome	8.24e-05	0.00295	CbGeAlD
Telaprevir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	8.17e-05	0.00124	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.16e-05	0.00124	CcSEcCtD
Telaprevir—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	8.1e-05	0.00123	CcSEcCtD
Telaprevir—Shock—Ritonavir—acquired immunodeficiency syndrome	8.05e-05	0.00123	CcSEcCtD
Telaprevir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	8.04e-05	0.00122	CcSEcCtD
Telaprevir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.03e-05	0.00122	CcSEcCtD
Telaprevir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	8.02e-05	0.00122	CcSEcCtD
Telaprevir—Dizziness—Stavudine—acquired immunodeficiency syndrome	8.01e-05	0.00122	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.99e-05	0.00122	CcSEcCtD
Telaprevir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.98e-05	0.00122	CcSEcCtD
Telaprevir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.98e-05	0.00122	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	7.96e-05	0.00596	CbGpPWpGaD
Telaprevir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.00121	CcSEcCtD
Telaprevir—Rash—Nevirapine—acquired immunodeficiency syndrome	7.91e-05	0.00121	CcSEcCtD
Telaprevir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.9e-05	0.0012	CcSEcCtD
Telaprevir—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.89e-05	0.0012	CcSEcCtD
Telaprevir—ABCB1—blood—acquired immunodeficiency syndrome	7.85e-05	0.00281	CbGeAlD
Telaprevir—Infection—Saquinavir—acquired immunodeficiency syndrome	7.83e-05	0.00119	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.00119	CcSEcCtD
Telaprevir—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.78e-05	0.00119	CcSEcCtD
Telaprevir—Shock—Saquinavir—acquired immunodeficiency syndrome	7.75e-05	0.00118	CcSEcCtD
Telaprevir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.00118	CcSEcCtD
Telaprevir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.73e-05	0.00118	CcSEcCtD
Telaprevir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.00118	CcSEcCtD
Telaprevir—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.7e-05	0.00117	CcSEcCtD
Telaprevir—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.66e-05	0.00117	CcSEcCtD
Telaprevir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.66e-05	0.00117	CcSEcCtD
Telaprevir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.00117	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.64e-05	0.00116	CcSEcCtD
Telaprevir—Rash—Stavudine—acquired immunodeficiency syndrome	7.64e-05	0.00116	CcSEcCtD
Telaprevir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.63e-05	0.00116	CcSEcCtD
Telaprevir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.63e-05	0.00116	CcSEcCtD
Telaprevir—ABCB1—bone marrow—acquired immunodeficiency syndrome	7.59e-05	0.00272	CbGeAlD
Telaprevir—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.59e-05	0.00116	CcSEcCtD
Telaprevir—ABCB1—spinal cord—acquired immunodeficiency syndrome	7.56e-05	0.0027	CbGeAlD
Telaprevir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.55e-05	0.00115	CcSEcCtD
Telaprevir—Rash—Abacavir—acquired immunodeficiency syndrome	7.53e-05	0.00115	CcSEcCtD
Telaprevir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.52e-05	0.00115	CcSEcCtD
Telaprevir—Infection—Lamivudine—acquired immunodeficiency syndrome	7.47e-05	0.00114	CcSEcCtD
Telaprevir—Nausea—Nevirapine—acquired immunodeficiency syndrome	7.45e-05	0.00114	CcSEcCtD
Telaprevir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	7.45e-05	0.00114	CcSEcCtD
Telaprevir—Shock—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.00113	CcSEcCtD
Telaprevir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	7.37e-05	0.00112	CcSEcCtD
Telaprevir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	7.36e-05	0.00112	CcSEcCtD
Telaprevir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	7.35e-05	0.00112	CcSEcCtD
Telaprevir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.00111	CcSEcCtD
Telaprevir—ABCB1—vagina—acquired immunodeficiency syndrome	7.27e-05	0.0026	CbGeAlD
Telaprevir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.22e-05	0.0011	CcSEcCtD
Telaprevir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	7.2e-05	0.0011	CcSEcCtD
Telaprevir—CTSK—Immune System—ACTG1—acquired immunodeficiency syndrome	7.2e-05	0.00539	CbGpPWpGaD
Telaprevir—Nausea—Stavudine—acquired immunodeficiency syndrome	7.2e-05	0.0011	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	7.17e-05	0.00537	CbGpPWpGaD
Telaprevir—Nausea—Abacavir—acquired immunodeficiency syndrome	7.09e-05	0.00108	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.00108	CcSEcCtD
Telaprevir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	7.06e-05	0.00108	CcSEcCtD
Telaprevir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	7.03e-05	0.00107	CcSEcCtD
Telaprevir—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.03e-05	0.00107	CcSEcCtD
Telaprevir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.96e-05	0.00106	CcSEcCtD
Telaprevir—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.93e-05	0.00106	CcSEcCtD
Telaprevir—ABCB1—lung—acquired immunodeficiency syndrome	6.88e-05	0.00246	CbGeAlD
Telaprevir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.00104	CcSEcCtD
Telaprevir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.79e-05	0.00104	CcSEcCtD
Telaprevir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.7e-05	0.00102	CcSEcCtD
Telaprevir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.7e-05	0.00102	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	6.69e-05	0.005	CbGpPWpGaD
Telaprevir—Rash—Zidovudine—acquired immunodeficiency syndrome	6.64e-05	0.00101	CcSEcCtD
Telaprevir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.64e-05	0.00101	CcSEcCtD
Telaprevir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.63e-05	0.00101	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.56e-05	0.00491	CbGpPWpGaD
Telaprevir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.55e-05	0.000998	CcSEcCtD
Telaprevir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.5e-05	0.000991	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000989	CcSEcCtD
Telaprevir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.48e-05	0.000988	CcSEcCtD
Telaprevir—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.48e-05	0.000987	CcSEcCtD
Telaprevir—ABCB1—nervous system—acquired immunodeficiency syndrome	6.37e-05	0.00228	CbGeAlD
Telaprevir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.35e-05	0.000968	CcSEcCtD
Telaprevir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.33e-05	0.000965	CcSEcCtD
Telaprevir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.26e-05	0.000955	CcSEcCtD
Telaprevir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.26e-05	0.000954	CcSEcCtD
Telaprevir—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.25e-05	0.000953	CcSEcCtD
Telaprevir—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.23e-05	0.000949	CcSEcCtD
Telaprevir—Rash—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.000941	CcSEcCtD
Telaprevir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.00094	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	6.15e-05	0.0046	CbGpPWpGaD
Telaprevir—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.13e-05	0.00219	CbGeAlD
Telaprevir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.12e-05	0.000933	CcSEcCtD
Telaprevir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.06e-05	0.000923	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	6.04e-05	0.00452	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.02e-05	0.00451	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.02e-05	0.00451	CbGpPWpGaD
Telaprevir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.97e-05	0.00091	CcSEcCtD
Telaprevir—CTSS—Immune System—ACTG1—acquired immunodeficiency syndrome	5.93e-05	0.00444	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MBL2—acquired immunodeficiency syndrome	5.92e-05	0.00443	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	5.91e-05	0.00442	CbGpPWpGaD
Telaprevir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.88e-05	0.000897	CcSEcCtD
Telaprevir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.87e-05	0.000895	CcSEcCtD
Telaprevir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.85e-05	0.000892	CcSEcCtD
Telaprevir—Rash—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000889	CcSEcCtD
Telaprevir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000888	CcSEcCtD
Telaprevir—Nausea—Indinavir—acquired immunodeficiency syndrome	5.82e-05	0.000887	CcSEcCtD
Telaprevir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.79e-05	0.000883	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	5.76e-05	0.00431	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	5.76e-05	0.00431	CbGpPWpGaD
Telaprevir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.65e-05	0.000862	CcSEcCtD
Telaprevir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.63e-05	0.000858	CcSEcCtD
Telaprevir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.6e-05	0.000854	CcSEcCtD
Telaprevir—Rash—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000851	CcSEcCtD
Telaprevir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.00085	CcSEcCtD
Telaprevir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.57e-05	0.00085	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.51e-05	0.00412	CbGpPWpGaD
Telaprevir—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.5e-05	0.000838	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	5.45e-05	0.00408	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.45e-05	0.00408	CbGpPWpGaD
Telaprevir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.41e-05	0.000825	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	5.4e-05	0.00404	CbGpPWpGaD
Telaprevir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000822	CcSEcCtD
Telaprevir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.39e-05	0.000822	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	5.39e-05	0.00403	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	5.38e-05	0.00403	CbGpPWpGaD
Telaprevir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.32e-05	0.000811	CcSEcCtD
Telaprevir—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.26e-05	0.000801	CcSEcCtD
Telaprevir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.21e-05	0.000794	CcSEcCtD
Telaprevir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000793	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	5.18e-05	0.00388	CbGpPWpGaD
Telaprevir—Rash—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000787	CcSEcCtD
Telaprevir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000786	CcSEcCtD
Telaprevir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.14e-05	0.000784	CcSEcCtD
Telaprevir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000764	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	4.99e-05	0.00373	CbGpPWpGaD
Telaprevir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.97e-05	0.000758	CcSEcCtD
Telaprevir—Rash—Saquinavir—acquired immunodeficiency syndrome	4.97e-05	0.000757	CcSEcCtD
Telaprevir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.000756	CcSEcCtD
Telaprevir—CTSS—Immune System—MBL2—acquired immunodeficiency syndrome	4.87e-05	0.00365	CbGpPWpGaD
Telaprevir—ABCB1—brain—acquired immunodeficiency syndrome	4.87e-05	0.00174	CbGeAlD
Telaprevir—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.86e-05	0.000741	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	4.85e-05	0.00363	CbGpPWpGaD
Telaprevir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000728	CcSEcCtD
Telaprevir—Rash—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000722	CcSEcCtD
Telaprevir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000722	CcSEcCtD
Telaprevir—ABCB1—lymph node—acquired immunodeficiency syndrome	4.71e-05	0.00168	CbGeAlD
Telaprevir—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.68e-05	0.000713	CcSEcCtD
Telaprevir—CTSK—Immune System—CCR2—acquired immunodeficiency syndrome	4.64e-05	0.00347	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.49e-05	0.00336	CbGpPWpGaD
Telaprevir—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.46e-05	0.000681	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.45e-05	0.00333	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.44e-05	0.00332	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.43e-05	0.00332	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.27e-05	0.0032	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IFNA1—acquired immunodeficiency syndrome	4.18e-05	0.00313	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD79A—acquired immunodeficiency syndrome	4.05e-05	0.00304	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CCR2—acquired immunodeficiency syndrome	3.82e-05	0.00286	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	3.78e-05	0.00283	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	3.78e-05	0.00283	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.72e-05	0.00279	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	3.68e-05	0.00275	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	3.6e-05	0.0027	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	3.6e-05	0.00269	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IFNA1—acquired immunodeficiency syndrome	3.44e-05	0.00257	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.37e-05	0.00252	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD79A—acquired immunodeficiency syndrome	3.34e-05	0.0025	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD40LG—acquired immunodeficiency syndrome	3.31e-05	0.00247	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD8A—acquired immunodeficiency syndrome	3.27e-05	0.00245	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CSF2—acquired immunodeficiency syndrome	3.27e-05	0.00245	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.22e-05	0.00241	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.16e-05	0.00237	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.16e-05	0.00237	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-B—acquired immunodeficiency syndrome	3.14e-05	0.00235	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.1e-05	0.00232	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	2.93e-05	0.00219	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.79e-05	0.00209	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD40LG—acquired immunodeficiency syndrome	2.72e-05	0.00204	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD8A—acquired immunodeficiency syndrome	2.69e-05	0.00201	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CSF2—acquired immunodeficiency syndrome	2.69e-05	0.00201	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.65e-05	0.00199	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	2.6e-05	0.00195	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HLA-B—acquired immunodeficiency syndrome	2.59e-05	0.00194	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.55e-05	0.00191	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.0018	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.37e-05	0.00177	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	2.33e-05	0.00174	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	2.33e-05	0.00174	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.22e-05	0.00166	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.00162	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.98e-05	0.00148	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IFNG—acquired immunodeficiency syndrome	1.94e-05	0.00146	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.9e-05	0.00142	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.88e-05	0.00141	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD4—acquired immunodeficiency syndrome	1.88e-05	0.00141	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.0014	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.74e-05	0.0013	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—acquired immunodeficiency syndrome	1.73e-05	0.00129	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IFNG—acquired immunodeficiency syndrome	1.6e-05	0.0012	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD4—acquired immunodeficiency syndrome	1.55e-05	0.00116	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.53e-05	0.00115	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.51e-05	0.00113	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.46e-05	0.0011	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.44e-05	0.00108	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.44e-05	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—acquired immunodeficiency syndrome	1.42e-05	0.00106	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.28e-05	0.00096	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000938	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.24e-05	0.000931	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.23e-05	0.000924	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.22e-05	0.00091	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.09e-05	0.000816	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—acquired immunodeficiency syndrome	1.02e-05	0.00076	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	9.9e-06	0.000741	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	9.66e-06	0.000723	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—acquired immunodeficiency syndrome	8.36e-06	0.000626	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	7.9e-06	0.000591	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.36e-06	0.000551	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	7.1e-06	0.000531	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	6.72e-06	0.000503	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	5.1e-06	0.000382	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.77e-06	0.000357	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.24e-06	0.000167	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.38e-06	0.000103	CbGpPWpGaD
